People: Amneal Pharmaceuticals Inc (AMRX.N)
24 Sep 2020
Mr. Shlomo Yanai serves as Independent Director of the Company. Mr. Yanai has more than 15 years of corporate leadership experience, primarily in the pharmaceutical industry. He served as President and Chief Executive Officer at Teva Pharmaceutical Industries Ltd. from 2007 to 2012. Mr. Yanai currently serves as an advisor to CVC Capital Partners, a private equity firm. In addition, he currently serves on the boards of PDL BioPharma Inc. and WR Grace & Co. He previously served on the boards of Cambrex Corp., Lumenis Ltd., Perrigo Company and Sagent Pharmaceuticals, among others, and held various leadership positions in the Israel Defense Forces.
|Total Annual Compensation, USD||--|
|Restricted Stock Award, USD||35,805|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||76,358|
|Fiscal Year Total, USD||112,163|